Xilio Therapeutics (XLO) Interest Coverage Ratio Growth (1y) (2021 - 2026)
Xilio Therapeutics (XLO) Interest Coverage Ratio Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Nanobiotix | 1,785.82 Bn | 1,785.76 Bn | - | - |
| 2 | Akari Therapeutics | 979.03 Bn | 979.03 Bn | - | -347.04% |
| 3 | BeOne Medicines | 473.13 Bn | 468.34 Bn | 1.35 Bn | 787.12% |
| 4 | Vertex Pharmaceuticals | 123.67 Bn | 116.43 Bn | 2.59 Bn | 53.59% |
| 5 | Regeneron Pharmaceuticals | 71.57 Bn | 62.81 Bn | 3.31 Bn | -32.04% |
| 6 | Belite Bio | 62.00 Bn | 62.00 Bn | - | -100.00% |
| 7 | Argenx Se | 54.61 Bn | 49.42 Bn | 1.41 Bn | - |
| 8 | Alnylam Pharmaceuticals | 37.99 Bn | 34.98 Bn | 959.66 Mn | 1,378.45% |
| 9 | Revolution Medicines | 36.09 Bn | 36.09 Bn | - | 73.00% |
| 10 | Xilio Therapeutics | 146.88 Mn | -3.42 Mn | - | -216.38% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -216.38% |
| Dec 31, 2025 | -807.04% |
| Sep 30, 2025 | 80.98% |
| Jun 30, 2025 | -338.40% |
| Mar 31, 2025 | -321.54% |
| Dec 31, 2024 | -188.70% |
| Sep 30, 2024 | 63.07% |
| Jun 30, 2024 | 67.84% |
| Mar 31, 2024 | 50.53% |
| Dec 31, 2023 | 9.39% |
| Sep 30, 2023 | -337.59% |
| Jun 30, 2023 | -190.49% |
| Mar 31, 2023 | -6.07% |
| Dec 31, 2022 | 90.55% |
| Sep 30, 2022 | -9,030.53% |
| Jun 30, 2022 | 60.91% |
| Mar 31, 2022 | -28.47% |
| Dec 31, 2021 | -795.43% |
| Sep 30, 2021 | 98.65% |